A tool for estimating antiretroviral medication coverage for HIV-infected women during pregnancy (PMTCT-ACT).
Bruce A LarsonNafisa HalimIsaac TsikhutsuMargaret BiiPeter CoakleyPeter C RockersPublished in: Global health research and policy (2019)
Evaluating the PMTCT cascade of care requires a standard definition of the follow-up period during pregnancy that applies to all HIV-infected pregnant women and a standard measure of adherence. PMTCT-ACT is a new tool that fits this purpose. PMTCT-ACT can also be easily adjusted to evaluate other ante- and post-natal periods (e.g., final 4 weeks, final 8 weeks, complete pregnancy period, initial 24 weeks postpartum, time periods consistent with infant HIV testing guidelines).
Keyphrases
- hiv infected
- antiretroviral therapy
- hiv testing
- pregnant women
- pregnancy outcomes
- men who have sex with men
- human immunodeficiency virus
- gestational age
- healthcare
- hiv positive
- south africa
- preterm birth
- palliative care
- hiv infected patients
- polycystic ovary syndrome
- hiv aids
- quality improvement
- type diabetes
- metabolic syndrome
- emergency department
- skeletal muscle
- chronic pain
- hepatitis c virus